Vutrisiran improved mortality and recurrent CV risks independent of disease severity and improved several other endpoints for ...

CHICAGO—A worsening Kansas City Cardiomyopathy Questionnaire overall summary (KCCQ-OS) score is associated with a higher risk of adverse outcomes in patients with transthyretin-mediated amyloid ...

主要研究终点包括：(1) 心血管死亡或首次心力衰竭住院的时间；(2) 心力衰竭总住院次数；(3) 在转铁蛋白饱和度 < 20% 的患者中，心血管死亡或首次心力衰竭住院的时间。 采用 Hochberg 统计方… ...

2025美国心脏病学会年度科学会议（ACC.25）重返密歇根湖畔的“风城”,于3月29日在美国芝加哥盛大举行。作为每年最受期待的全球心血管领域峰会之一，ACC.2025汇聚全球的顶尖专家、学者，共同探讨心血管疾病预防、诊断和治疗的最新突破与前沿进展； ...

Additionally, valve-replacement group patients reported higher quality-of-life scores, as measured by the Kansas City Cardiomyopathy Questionnaire overall summary (KCCQ-OS). They also demonstrated ...

MacOS Sequoia 15.4 has been released for Mac users running the Sequoia operating system. The software update includes some new features and refinements, as well as resolutions to various bugs and ...

We have provided two different methods to download the latest ChromeOS Flex. Updated on March 29, 2025: Added the latest stable version of Chrome OS Flex (V134). Updated on 23-Jul-2022: Google ...

The ALIGN-AR trial contributes to the literature by demonstrating high technical success, a reassuring safety profile, and favorable clinical outcomes in high-risk patients with aortic regurgitation ...

2025.3.19: 2025年春夏季开源操作系统训练营发布重要信息，请仔细阅读。 2025.3.15: 2025年春夏季开源操作系统训练营准备中。 给 ...

The majority of participants (87.1%) had NYHA class II symptoms, and most were taking standard HF medication; 51% were taking loop diuretics. Their median baseline KCCQ Overall Summary Score (KCCQ-OSS ...

试验的主要结局是 3 个月后的健康状况，通过堪萨斯城心肌病问卷总体总结评分（KCCQ-OSS）评估。次要结局包括口渴不适和安全事件。在 504 名随机分组的患者（男性占 67.3%）中，自由液体摄入组 3 个月后的 KCCQ-OSS 为 74.0，液体限制组为 72.2，经基线评分调整后的 ...